SOCS1 and prostate cancer: Future studies are needed to explore the association with miR-221-5p and SOCS1, and whether miR-221-5p/SOCS1 pair can be used as a new biomarker to diagnosis of prostate cancer, and whether it can be as a novel therapeutic target in prostate cancer treatment.